Cyclerion Therapeutics shareholders re-elect all five directors, ratify Ernst & Young as auditor

Cyclerion Therapeutics, Inc.

Each of five director nominees (De Souza, Hecht, Hyman, Higgins, Katabi) elected with for votes ranging from 1,670,155 to 1,688,966.
Ernst & Young ratified as independent auditor for FY 2024 with 2,140,990 votes for, 47,974 against, 8,751 abstain.
Proposal to adjourn annual meeting if necessary approved with 2,111,217 for, 86,202 against, 296 abstain.
Broker non-votes on director election were 454,351 for each nominee; no other proposals had broker non-votes.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.